Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System (Q27004790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Angela Alama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Simona Coco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Irene Vanni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Carlo Genova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Francesco Grossi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Francesco Grossi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Maria Giovanna Dal Bello

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Erika Rijavec

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Giulia Barletta

8

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Federica Biello

9

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

1 reference

4 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

published in

Frontiers in Oncology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

242

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

Ceritinib in ALK-rearranged non-small-cell lung cancer

16 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

21 March 2017

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Pemetrexed for the treatment of non-small cell lung cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Circulating tumor cells as a window on metastasis biology in lung cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Circulating tumor cell as a diagnostic marker in primary lung cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

28 September 2017

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Prognostic impact of circulating tumor cells in patients with small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFONC.2014.00242

Simultaneous phenotypic and genetic characterization of single circulating tumor cells from colon cancer patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4154446

Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25237652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25237652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method

1 reference

https://pubmed.ncbi.nlm.nih.gov/25237652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FONC.2014.00242

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

25237652

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25237652%20AND%20SRC:MED&resulttype=core&format=json